Closure of Trading Window for the half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aspira Pathlab & Diagnostics has informed the stock exchanges that its trading window will be closed starting October 1, 2025. The closure applies to designated persons and their immediate relatives and will remain in effect until the company declares its financial results for the half year ended September 30, 2025, plus 48 hours thereafter. This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015. The date of the board meeting to announce these results will be communicated later.
This is a standard regulatory disclosure and does not directly impact shareholders. However, it signals that the company's H1 FY26 financial results are upcoming, which investors should watch for potential stock movement once results are announced and the trading window reopens.